The U.S. Attorney’s office in Boston announced that the Justice Department has filed a False Claims Act complaint against Johnson & Johnson and two subsidiaries for allegedly paying millions of dollars in kickbacks to nursing homes to prescribe its anti-psychotic drug Risperdal . New Jersey-based Johnson & Johnson allegedly paid the kickbacks to Omnicare, the nation’s
Go here to read the rest:
Justice Dept. joins Risperdal whistleblower suits
